2026 ICD-10-CM Diagnosis Code C88.20Heavy chain disease not having achieved remission
ICD-10-CM Codes›C00–D49›C81-C96›C88
- Billable — Valid for Submission
- Chronic Condition
C88.20 is a billable ICD-10-CM diagnosis code for heavy chain disease not having achieved remission. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 820 through 825, 840 through 842. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Non-Hodgkin lymphoma.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Gamma heavy chain disease
- Glomerular disease due to neoplastic disease
- Heavy chain deposition disease
- Heavy chain disease
- Monoclonal abnormal heavy chain protein devoid of light chains detected
- Monoclonal gamma heavy chain detected
- Monoclonal mu heavy chain detected
- Mu heavy chain disease
- Nodular glomerulosclerosis due to heavy chain deposition disease
- Non-amyloid monoclonal immunoglobulin deposition disease
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Franklin disease NOS
- Franklin disease not having achieved remission
- Franklin disease with failed remission
- Gamma heavy chain disease NOS
- Gamma heavy chain disease not having achieved remission
- Gamma heavy chain disease with failed remission
- Heavy chain disease NOS
- Heavy chain disease with failed remissionMu heavy chain disease not having achieved remission
- Mu heavy chain disease NOS
- Mu heavy chain disease not having achieved remission
- Mu heavy chain disease with failed remission
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Heavy Chain Disease
a disorder of immunoglobulin synthesis in which large quantities of abnormal heavy chains are excreted in the urine. the amino acid sequences of the n-(amino-) terminal regions of these chains are normal, but they have a deletion extending from part of the variable domain through the first domain of the constant region, so that they cannot form cross-links to the light chains. the defect arises through faulty coupling of the variable (v) and constant (c) region genes.Immunoproliferative Small Intestinal Disease
a condition that is caused by hyperplasia of lymphocytes in the small intestine (intestine, small) and the mesenteric lymph nodes. these lymphocytes produce an anomalous alpha heavy chain protein. generally, these ipsid patients have either concurrent lymphoma or develop lymphoma within a few years. the disease was first described in the mediterranean region and is characterized by malabsorption; weight loss; diarrhea; and steatorrhea.
Code History & ChangesHistory
Replacement C88.20 replaces the following previously assigned code(s):
- C88.2 - Heavy chain disease
Questions About C88.20Overview
Is C88.20 (Heavy chain disease) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report heavy chain disease not having achieved remission on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does C88.20 group to?
When heavy chain disease not having achieved remission is the principal diagnosis on an inpatient stay, it groups to MS-DRG 820, 821, 822, 823, 824, 825, 840, 841, 842, with relative weights from 1.0104 to 5.8648 depending on complications. Higher weights mean higher Medicare reimbursement.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
